MESORIDAZINE BESYLATE INJECTION. Key specifications include administration: INTRAMUSCULAR, special_features: MESORIDAZINE AS THE BESYLATE, primary_container_type: AMPUL, medical_designation_and_grade: UNITED STATES PHARMACOPEIA, total_primary_container_quantity: 20, primary_container_content_quantity: 1.000 MILLILITERS. This product is currently in active production with full OEM support.
This part is cataloged in the Federal Logistics Information System (FLIS) under NSN 6505-00-159-8115, indicating validated use in U.S. government and defense logistics supply chains. Available through authorized enterprise resellers and TPM (Third Party Maintenance) channels.
Verify compatibility with your specific system configuration before ordering.
| administration | INTRAMUSCULAR |
| special_features | MESORIDAZINE AS THE BESYLATE |
| primary_container_type | AMPUL |
| medical_designation_and_grade | UNITED STATES PHARMACOPEIA |
| total_primary_container_quantity | 20 |
| primary_container_content_quantity | 1.000 MILLILITERS |
| active_medicament_medicinal_strength | 25.000 MILLIGRAMS MESORIDAZINE PER MILLILITER |
| NSN | 6505-00-159-8115 |
| PRIMARY CONTAINER CONTENT QUANTITY | 1.000 MILLILITERS |
| MEDICAL DESIGNATION AND GRADE | UNITED STATES PHARMACOPEIA |
| TOTAL PRIMARY CONTAINER QUANTITY | 20 |
| ACTIVE MEDICAMENT MEDICINAL STRENGTH | 25.000 MILLIGRAMS MESORIDAZINE PER MILLILITER |
| ADMINISTRATION | INTRAMUSCULAR |
| SPECIAL FEATURES | MESORIDAZINE AS THE BESYLATE |
| PRIMARY CONTAINER TYPE | AMPUL |